Pharmacy & Biological SciencesCategory
The problem isn’t new and it isn’t going away by itself. But it is getting more and more attention. Mainly due to the fact that a diverse science and engineering workforce is absolutely critical for innovation, entrepreneurism, and a competitive national economy.
The new grants will support the development of methods needed to integrate genome sequencing into the practice of medicine, improve the discovery and interpretation of genomic variants, and investigate the impact of genome sequencing on healthcare outcomes.
While the pharma industry spends upwards of $2B on patient recruitment every year, a recent survey found half of respondents were not aware of clinical trials.
The most recent new treatment for Alzheimer’s disease was approved by European regulators in May 2002, with the US FDA following suit the next year.
All 10 regions ranked have significant assets that make them attractive to biopharma researchers, executives, and investors.
Recent lawsuits are asking courts whether the current crisis is comparable to the one over tobacco in the ’90s.
For years, clinics across the country have been offering experimental stem cell therapies, but no state has given them legal validation—yet.
The FDA can’t regulate drug prices, but it can implement measures aimed at deterring the types of price hikes that have made so many headlines over more than a year.
How a proposed tax penalty on drugs with price increases exceeding the inflation could impact patients, public insurance programs, and innovation.
Researchers found nearly a third of approvals from 2001 through 2010 had major safety issues years after they were widely available to patients.